SCHEMBL6167784

SCHEMBL6167784

CCOC(=O)c1ccc([N+](=O)[O-])c(N(Cc2ccccc2Cl)C(=O)c2ccccc2)c1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 6/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
MAPT P10636 6/20 0.46
RAB9A P51151 3/20 0.42
NPC1 O15118 1/20 0.42
PKM P14618 1/20 0.42
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
POLB P06746 2/20 0.41
LMNA P02545 1/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
PTGER4 P35408 1/20 0.40
HTT P42858 1/20 0.40
MAPK1 P28482 1/20 0.40
THRB P10828 1/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170389 0.90 KMT2A (0.48) KMT2AMEN1ALDH1A1SMN1; SMN2MAPT
SCHEMBL6170305 0.87 KMT2A (0.46) KMT2AMEN1ALDH1A1SMN1; SMN2MAPT
SCHEMBL6169083 0.82 MAPT (0.49) KMT2AMEN1ALDH1A1SMN1; SMN2MAPT
SCHEMBL6170395 0.80 KMT2A (0.48) KMT2AMEN1ALDH1A1SMN1; SMN2MAPT
SCHEMBL6170740 0.80 KMT2A (0.46) KMT2AMEN1ALDH1A1SMN1; SMN2MAPT
SCHEMBL6170467 0.80 KMT2A (0.52) KMT2AMEN1ALDH1A1SMN1; SMN2MAPT
SCHEMBL6428077 0.79 RAB9A (0.43) KMT2AMEN1ALDH1A1SMN1; SMN2MAPT
SCHEMBL6169759 0.79 KMT2A (0.43) KMT2AMEN1ALDH1A1SMN1; SMN2MAPT
SCHEMBL6170369 0.79 KMT2A (0.47) KMT2AMEN1ALDH1A1SMN1; SMN2MAPT
SCHEMBL6169314 0.79 KMT2A (0.45) KMT2AMEN1ALDH1A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed